Whereas no significant or very low percentages of ex vivo IL-22 or IL-17A-containing T lymphocytes were observed in healthy controls, IL-22+ and IL-17A+ single positive CD4+ and IL-17A+ CD8+ T cells were detected in COVID-19 patients. This evidence concerns the gene CD4 and COVID-19.